Skip to main content
TipRanks
Go Ultimate75% OFF

Bicycle Therapeutics (50BA) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

50BA Analyst Ratings

Hold
2Ratings
0Buy2Hold0Sell
Based on 2 analysts giving stock ratings to Bicycle Therapeutics in the past 3 months

50BA Stock 12 Month Forecast

EUR 4.46▲(44.81% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Bicycle Therapeutics in the last 3 months. The average price target is EUR 4.46 with a high forecast of EUR 4.46 and a low forecast of EUR 4.46. The average price target represents a 44.81% change from the last price of EUR 3.08.
Highest Price TargetEUR 4.46Average Price TargetEUR 4.46Lowest Price TargetEUR 4.46

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:50BA
Price TargetArticle
RBC CapitalEUR 4.46hold44.81%UpsideReiterated10/29/26
Morgan Stanley―hold―Reiterated08/17/26
Truist FinancialEUR 6.24hold102.74%UpsideReiterated07/31/26
OppenheimerEUR 32.11→EUR 9.81buy218.59%UpsideInitiated07/31/26
NeedhamEUR 13.38→EUR 12.49buy305.48%UpsideReiterated07/30/26
TD Cowen―buy―Reiterated07/30/26
JefferiesEUR 11.60→EUR 10.70buy247.55%UpsideReiterated04/30/26
Citizens JMPEUR 10.70→EUR 7.14buy131.70%UpsideReiterated03/18/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
HELPHelus Pharma
IMUXImmunic
CABACabaletta Bio
MDWDMediwound
OVIDOvid Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Bicycle Therapeutics

3 Months
Reni Benjamin
Reni BenjaminCitizens JMP
Success Rate13/34 ratings generated profit
38%
Average Return
-5.05%

Copying Reni Benjamin's trades and holding each position for 3 Months would result in 38.24% of your transactions generating a profit, with an average return of -5.05% per trade.

1 Year
Reni Benjamin
Reni BenjaminCitizens JMP
Success Rate8/34 ratings generated profit
24%
Average Return
-27.28%

Copying Reni Benjamin's trades and holding each position for 1 Year would result in 23.53% of your transactions generating a profit, with an average return of -27.28% per trade.

2 Years
Ami Fadia
Ami FadiaNeedham
Success Rate2/34 ratings generated profit
6%
Average Return
-49.85%

Copying Ami Fadia's trades and holding each position for 2 Years would result in 5.88% of your transactions generating a profit, with an average return of -49.85% per trade.

50BA Analyst Recommendation Trends

05101520Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for 50BA
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy42200
Buy11100
Hold43321
Sell00000
Strong Sell00000
total96621

In the current month, 50BA has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. 50BA average Analyst price target in the past 3 months is 4.46.

50BA Financial Forecast

EUR -2EUR -1.25EUR -0.5EUR 0.25EUR 1Q1 2026Q3 2026Q4 2026
HighEUR 0.25
ConsensusEUR -0.39
LowEUR -0.63

50BA Earnings Forecast

Next quarter’s earnings estimate for 50BA is -EUR 0.39 with a range of -EUR 0.63 to EUR 0.25. The previous quarter’s EPS was -EUR 0.13. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

EUR 179,359EUR 10.9MEUR 21.6MEUR 32.3MEUR 42.9MQ1 2026Q3 2026Q4 2026
HighEUR 12.9M
ConsensusEUR 2.27M
LowEUR 179K

50BA Sales Forecast

Next quarter’s sales forecast for 50BA is EUR 2.27M with a range of EUR 179.36K to EUR 12.91M. The previous quarter’s sales results were EUR 30.53M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

50BA Stock Forecast FAQ

What is DE:50BA’s average 12-month price target, according to analysts?
Based on analyst ratings, Bicycle Therapeutics’s 12-month average price target is €4.46.
What is DE:50BA’s upside potential, based on the analysts’ average price target?
Bicycle Therapeutics has 44.81% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Bicycle Therapeutics a Buy, Sell or Hold?
Bicycle Therapeutics has a consensus rating of Hold, which is based on 0 buy ratings, 2 hold ratings and 0 sell ratings.
What is Bicycle Therapeutics’s share price target?
The average share price target for Bicycle Therapeutics is €4.46. This is based on 2 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €4.46, and the lowest forecast is €4.46. The average share price target represents a 44.81% increase from the current price of €3.08.
What do analysts say about Bicycle Therapeutics?
Bicycle Therapeutics’s analyst rating consensus is a Hold. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of Bicycle Therapeutics?
To buy shares of DE:50BA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.